Caretrust Stock Price, News & Analysis

CareTrust REIT, Inc. (NYSE: CTRE) has renewed its unsecured revolving credit facility, extending the maturity to February 2027. CEO Dave Sedgwick expressed gratitude for the bank group's support during tough credit conditions, highlighting that this facility is crucial for future acquisitions. The amended facility features grid-based pricing tied to adjusted SOFR, with a potential accordion feature allowing an additional $500 million in capacity, subject to standard terms.

CareTrust REIT has declared a quarterly cash dividend of $0.275 per common share, with a record date of December 30, 2022. The dividend is set to be paid on or about January 13, 2023. This distribution reflects the company's commitment to return value to its shareholders. CareTrust REIT focuses on real estate investments in the healthcare sector, including skilled nursing and senior housing, with an aim for organic and external growth across the United States.

The Board of Directors of CareTrust REIT (NYSE:CTRE) announced the appointment of James Callister as the new Chief Investment Officer effective December 31, 2022. He succeeds Mark Lamb, who is leaving to pursue entrepreneurial opportunities. Mr. Callister has been with CareTrust as Executive Vice President and has significant experience in healthcare REIT transactions, having closed over $2.5 billion in acquisitions. Both the CEO and Mark Lamb expressed confidence in Callister's leadership and the company's growth prospects moving forward.

CareTrust REIT (CTRE) reported Q3 2022 results, highlighting 93.4% of contractual rents collected and a net income of $0.7 million, or $0.01 per share. The normalized FFO reached $36.1 million, with a dividend of $0.275 per share, a 71% payout ratio on normalized FAD. For the quarter, skilled nursing occupancy increased by 0.7%, while seniors housing occupancy grew by 1.7%. The company also announced the sale of the Trio skilled nursing portfolio for $52 million and successfully financed two skilled nursing portfolios worth over $47 million, indicating a stable operational environment. A conference call is scheduled for November 9.

CareTrust REIT (NYSE:CTRE) plans to release its Q3 2022 financial results on November 8, 2022, after U.S. market close. The management team will host a conference call on November 9, 2022, at 1:00 PM ET to discuss the results. Investors can join the call through a toll-free number or access it via webcast on their website. CareTrust REIT focuses on the acquisition and leasing of healthcare-related properties across the U.S., aiming for both organic and external growth in its operations.

CareTrust REIT, Inc. (NYSE:CTRE) has successfully completed the sale of seven skilled nursing facilities in Ohio for $52 million. This transaction results in the termination of the company’s master lease with Trio Healthcare. The facilities encompass around 600 skilled nursing beds and approximately 100 seniors housing beds. CEO Dave Sedgwick emphasized the significance of this achievement in the context of their strategy to de-risk the portfolio, with plans to address the remaining 25 properties by year-end.

CareTrust REIT (NYSE:CTRE) has declared a quarterly cash dividend of $0.275 per share for common stockholders. This dividend is payable on or about October 14, 2022 to stockholders of record by the close of business on September 30, 2022. As a publicly traded real estate investment trust, CareTrust REIT focuses on the ownership and leasing of healthcare-related properties, enhancing its portfolio across the United States.

CareTrust REIT, Inc. (NYSE:CTRE) announced a $24.9 million B-piece secured financing for a portfolio of four skilled nursing assets located in the Southeast, comprising around 700 beds. The loan has a three-year maturity with two one-year extensions and an annual interest rate of 9.00%. Funded with cash on hand, this financing marks the beginning of a new partnership with a Southeast operator, with plans to explore further growth opportunities through acquisitions and leaseback activities.